Dexcom Inc
(DXCM)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 709,200 | 1,285,100 | 1,137,000 | 367,400 | 300,200 |
| Marketable Securities | 668,300 | 72,900 | 248,600 | 301,300 | 305,900 |
| Receivables | 217,300 | 204,700 | 226,700 | 169,800 | 162,000 |
| Inventories | 117,900 | 101,100 | 70,700 | 55,200 | 46,200 |
| TOTAL | $1,744,200 | $1,690,800 | $1,699,500 | $914,100 | $836,000 |
| Non-Current Assets | |||||
| PPE Net | 253,200 | 221,400 | 183,100 | 169,600 | 156,800 |
| Intangibles | 18,700 | 18,600 | 18,700 | 18,400 | 11,900 |
| Other Non-Current Assets | 49,800 | 43,200 | 14,700 | 12,200 | 2,800 |
| TOTAL | $321,700 | $283,200 | $216,500 | $200,200 | $171,500 |
| Total Assets | $2,065,900 | $1,974,000 | $1,916,000 | $1,114,300 | $1,007,500 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 196,700 | 169,100 | 147,100 | 135,400 | 117,900 |
| Accrued Expenses | 73,900 | 51,300 | 72,400 | 55,000 | 46,100 |
| TOTAL | $288,200 | $235,400 | $222,400 | $193,900 | $170,800 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,034,700 | 1,022,400 | 1,010,300 | 338,800 | 335,000 |
| Deferred Revenues | 3,500 | 2,700 | 2,900 | 3,500 | 6,800 |
| Other Non-Current Liabilities | 54,700 | 47,600 | 20,000 | 19,400 | 19,600 |
| TOTAL | $1,089,400 | $1,070,000 | $1,030,300 | $358,200 | $354,600 |
| Total Liabilities | $1,377,600 | $1,305,400 | $1,252,700 | $552,100 | $525,400 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 364,744 | 364,202 | 360,007 | 355,377 | 353,423 |
| Common Shares | 100 | 100 | 100 | 100 | 100 |
| Retained earnings | -834,200 | -823,700 | -798,900 | -619,200 | -665,800 |
| Other shareholders' equity | 2,000 | 1,600 | 1,500 | -300 | -1,300 |
| TOTAL | $688,300 | $668,600 | $663,300 | $562,200 | $482,100 |
| Total Liabilities And Equity | $2,065,900 | $1,974,000 | $1,916,000 | $1,114,300 | $1,007,500 |